发明名称 DYNAMIC BH3 PROFILING
摘要 The present invention provides methods of predicting cell sensitivity or resistance to a therapeutic agent.
申请公布号 US2015362479(A1) 申请公布日期 2015.12.17
申请号 US201314429272 申请日期 2013.09.19
申请人 DANA-FARBER CANCER INSTITUTE, INC. 发明人 Letai Anthony;Montero Boronat Juan Jose;Ryan Jeremy
分类号 G01N33/50 主分类号 G01N33/50
代理机构 代理人
主权项 1. A method of predicting sensitivity of a cell to a therapeutic agent comprising: a) contacting a test cell population that has been exposed to a test therapeutic agent with a pro-apoptotic BH3 domain peptide; b) measuring the amount of BH3 domain peptide induced mitochondrial outer membrane permeabilization in the test cell population; and c) comparing the amount of BH3 domain peptide induced mitochondrial outer membrane membrane permeabilization in the test cell population to a control cell population that has not been contacted with the therapeutic agent, wherein an increase in mitochondrial outer membrane permeabilization in the test cell population compared to the control cell population indicates the cell is sensitive to the therapeutic agent.
地址 Boston MA US